Embla Medical hf: Conference call details for Q4/FY 2024

Report this content

Reykjavik, Iceland/Copenhagen, Denmark, January 9, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q4/Full Year 2024 Report on 5 February 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 8:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly and full year results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors

To participate in the telephone conference, please use the dial-in details provided below:

DK: +45 78 76 84 90

SE: +46 31-311 50 03

UK: +44 20 3769 6819

US: +1 646 787 0157

Participant access code: 274982

The webcast will be available through following link:  Embla Medical Q4/FY 2024 webcast

Financial calendar and events 2025

9 Jan 2025                     SEB Nordic Seminar, Copenhagen

5 Feb 2025                     2024 Annual Report

5 Feb 2025                     Q4/FY presentation and virtual Q&A (HCA Capital)

6 Feb 2025                     Q4/FY Road Show Copenhagen (ABG)

7 Feb 2025                     Q4/FY Road Show Stockholm (ABG)

10 Feb 2025                   Q4/FY Road Show London (Intron Health)

11-12 Feb 2025              Q4/FY Road Show New York City/East Coast (SEB)

26-27 Feb 2025              Q4/FY Road Show Benelux (DNB)

12 Mar 2025                   2025 Annual General Meeting

26-27 Mar 2025              DNB Nordic-American Healthcare Conference, New York City

29 April 2025                  Interim report Q1 2025

28 May 2025                  Redeye Orthopedic Event, Stockholm

3 June 2025                   Carnegie Healthcare Day, Paris

22 July 2025                  Interim report Q2 2025

27 Aug 2025                  Økonomisk Ugebrev Life Science Conference, Copenhagen

4-5 Sept 2025                Goldman Sachs MedTech conference, London

16 Sept 2025                 Pareto Securities Annual Healthcare Conference, Stockholm

21 Oct 2025                   Interim Report Q3 2025

If you wish to receive Embla Medical press releases by e-mail, please register here

For further information please contact

Klaus Sindahl

Head of Investor Relations

M: +45 5363 0134

E: ksindahl@emblamedical.com

About Embla Medical

Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people‘s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people‘s health and well-being.

Subscribe

Documents & Links